What is NKNSF?
engages in the manufacture and sale of dental, surgical, and general industrial products in Japan and internationally.
NKNSF · Verdict
Solid reward · moderate risk
NKNSF scores well on cash flow and volatility with no major weaknesses flagged in the model.
Based on 88% data coverage
NKNSF · Verdict
13% free-cash-flow margin
Above average
11% net margin · -2% ROE
Model-based scoring. For information only — not financial advice.
engages in the manufacture and sale of dental, surgical, and general industrial products in Japan and internationally. The company offers dental equipment and chairs; air turbines; contra-angles; therapeutic motors; home visit medical equipment; oral hygiene products; endotherapy; oral surgery; maintenance and autoclave products; and technical products. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 1.17B, and a P/E ratio of 30.7x.
The scoring profile indicates moderate reward potential, with profitability and valuation as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.